Cantargia AB (publ)

Stockholm Stock Exchange:CANTA.ST

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

Sweden

Market Cap

USD 75.46 M

Share Price

USD 0.30

Avg Daily Volume

4,725,677

Change (1 day)

-1.97%

Change (1 year)

-12.72%

Change (YTD)

98.88%

Cantargia AB (publ) EBIT Margin for the year ending August 17, 2025: N/A

Cantargia AB (publ) EBIT Margin is NA for the year ending August 17, 2025. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Competitors

Eli Lilly and Company

USD 701.23

LLY

+16.80 2.46%

AbbVie Inc.

USD 206.69

ABBV

+2.01 0.98%

Roche Holding AG

USD 331.61

RO.SW

+7.43 2.29%

Novartis AG

USD 123.29

NOVN.SW

+1.51 1.24%

AstraZeneca PLC

USD 150.15

AZN.L

-2.01 -1.32%

Novo Nordisk A/S

USD 50.97

NOVO-B.CO

+0.44 0.87%

Merck & Co., Inc.

USD 84.21

MRK

+1.45 1.75%

Thermo Fisher Scientific Inc.

USD 489.01

TMO

+3.97 0.82%

Amgen Inc.

USD 296.47

AMGN

+6.18 2.13%

Gilead Sciences, Inc.

USD 118.37

GILD

-0.65 -0.55%

Pfizer Inc.

USD 25.14

PFE

+0.03 0.12%

Sanofi

USD 99.43

SAN.PA

+2.12 2.18%

Vertex Pharmaceuticals Incorporated

USD 392.79

VRTX

+2.49 0.64%

Bristol-Myers Squibb Company

USD 48.44

BMY

+0.63 1.32%

Chugai Pharmaceutical Co., Ltd.

USD 42.42

4519.T

+0.95 2.29%

View all

Key Data

Date	EBIT Margin	EBITDA Margin	Net Income Margin	EBT Margin